CliffBio
small molecule

CUPRIC SULFATE

CUPRIC SULFATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameCUPRIC SULFATE
Active ingredientCUPRIC SULFATE
StrengthEQ 0.4MG COPPER/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalAugust 2024
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.